This study will be performed to evaluate the safety, tolerability and pharmacokinetics of single and multiple doses of AZD0328 when administered to Japanese and Caucasian healthy male volunteers.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
DOUBLE
Enrollment
64
Oral solution A single dose Day 1 followed by once daily doses on Day 3-7
Research Site
London, United Kingdom
Safety variables (adverse events, vital signs, paper ECGs and 12-lead continuous digital ECGs including QT/QTc interval measurements
Time frame: During the whole treatment period
PK variables
Time frame: Several samples during the study days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.